Phathom Pharmaceuticals Inc.
PHAT | NASDAQ
$7.73
+$0.28 (+3.76%)
Sep 22, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 239.66M | 204.89M | 175.11M | 147.19M | 114.04M | 81.86M | 55.25M | 26.27M | 9.92M | 2.59M | 682K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 40.93M | 30.87M | 22.6M | 18.77M | 14.93M | 11.27M | 7.97M | 4.51M | 2.28M | 1.02M | 596K | 412K | 466K | 492K | 620K | 587K | 542K | 524K | 521K | 386K | 256K | 125K |
Gross Profit | 198.73M | 174.02M | 152.51M | 128.42M | 99.11M | 70.59M | 47.28M | 21.76M | 7.64M | 1.57M | 86K | -412K | -466K | -492K | -620K | -587K | -542K | -524K | -521K | -386K | -256K | -125K |
Operating Income | -40.64M | -96.6M | -159.99M | -213.48M | -269M | -286.38M | -277.47M | -287.92M | -252.79M | -207.19M | -167.31M | -144.08M | -150.95M | -164.61M | -172.44M | -158.84M | -149.45M | -139.4M | -135.08M | -154.48M | -154.17M | -138.87M |
Interest Income | 5.86M | 6.14M | 7.04M | 9.35M | 11.65M | 13.49M | 15.16M | 15M | 14.01M | 10.73M | 7.88M | 5.81M | 3.82M | 3.58M | 2.13M | 851K | 133K | 34K | 41K | 51K | 58K | 227K |
Pretax Income | -81.49M | -157.3M | -221.25M | -274.55M | -330.15M | -345.79M | -334.33M | -339.44M | -297.11M | -246.63M | -201.59M | -177.07M | -184.92M | -194.87M | -197.72M | -178.5M | -164.07M | -149.71M | -143.88M | -161.78M | -159.22M | -143.77M |
Net Income | -81.49M | -157.3M | -221.25M | -274.55M | -330.15M | -345.79M | -334.33M | -339.44M | -297.11M | -246.63M | -201.59M | -177.07M | -184.92M | -194.87M | -197.72M | -178.5M | -164.07M | -149.71M | -143.88M | -161.78M | -159.22M | -143.77M |
Selling & General & Admin | 209.27M | 239.25M | 279.72M | 308.03M | 332.57M | 323.13M | 290.66M | 270.79M | 217.97M | 161.03M | 117.62M | 91.34M | 91.4M | 99.01M | 100.53M | 89.49M | 82.68M | 69.86M | 62.74M | 54.04M | 44.57M | 36.01M |
Research & Development | 30.1M | 31.37M | 32.78M | 33.87M | 35.54M | 33.84M | 34.08M | 38.89M | 42.46M | 47.85M | 49.9M | 52.45M | 59.21M | 65.26M | 71.44M | 69.05M | 66.64M | 69.42M | 72.34M | 100.44M | 109.6M | 102.86M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 3K | -2K | -2K | -19K | -19K | -7K | -8K | 7K | 3K | -7K |
Operating Expenses | 239.37M | 270.62M | 312.5M | 341.9M | 368.11M | 356.96M | 324.75M | 309.68M | 260.43M | 208.88M | 167.52M | 143.79M | 150.61M | 164.27M | 171.97M | 158.54M | 149.32M | 139.27M | 135.08M | 154.48M | 154.17M | 138.87M |
Interest Expense | 33.22M | 65.84M | 68.12M | 70.29M | 72.67M | 72.91M | 72.01M | 66.45M | 58.07M | 49.92M | 41.97M | 38.54M | 37.71M | 33.76M | 27.31M | 20.48M | 12.69M | 8.28M | 6.79M | 5.31M | 5.11M | 5.12M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 280.3M | 301.49M | 335.1M | 360.67M | 383.04M | 368.24M | 332.72M | 314.19M | 262.71M | 209.78M | 167.99M | 144.08M | 150.95M | 164.61M | 172.44M | 158.84M | 149.45M | 139.4M | 135.08M | 154.48M | 154.17M | 138.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 83.75M | 82.05M | 73.82M | 73.4M | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M | 37.3M | 36.64M | 36.3M |
Shares Outstanding (Diluted) | 83.75M | 82.05M | 73.82M | 73.4M | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M | 37.3M | 36.64M | 36.3M |
EPS (Basic) | -1.28 | -2.12 | -3.06 | -3.82 | -4.73 | -5.24 | -5.35 | -5.69 | -5.13 | -4.41 | -3.88 | -4.03 | -4.81 | -5.30 | -5.55 | -4.96 | -4.40 | -4.07 | -3.89 | -4.52 | -4.56 | -4.20 |
EPS (Diluted) | -1.28 | -2.12 | -3.06 | -3.82 | -4.73 | -5.24 | -5.35 | -5.69 | -5.13 | -4.41 | -3.88 | -4.03 | -4.81 | -5.30 | -5.55 | -4.96 | -4.40 | -4.07 | -3.89 | -4.52 | -4.56 | -4.20 |
EBITDA | -36.74M | -90.89M | -152.5M | -203.56M | -256.76M | -272.12M | -261.52M | -272.21M | -238.33M | -196.07M | -159.05M | -137.97M | -146.59M | -160.47M | -169.8M | -157.44M | -150.85M | -140.91M | -136.57M | -155.99M | -153.68M | -138.27M |
EBIT | -33.17M | -91.46M | -153.13M | -204.26M | -257.49M | -272.88M | -262.32M | -273M | -239.04M | -196.71M | -159.62M | -138.53M | -147.21M | -161.11M | -170.42M | -158.02M | -151.39M | -141.43M | -137.1M | -156.47M | -154.11M | -138.66M |
Depreciation & Amortization | 394K | 566K | 633K | 698K | 733K | 758K | 795K | 787K | 717K | 643K | 575K | 558K | 612K | 638K | 620K | 587K | 542K | 524K | 521K | 492K | 450K | 396K |
Add to Watchlist
Select watchlists to add or remove PHAT